Argenx
ARGX
#455
Rank
โ‚น5.279 T
Marketcap
โ‚น84,386
Share price
3.37%
Change (1 day)
72.63%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total debt

Total debt on the balance sheet as of December 2025 : โ‚น4.54 Billion

According to Argenx 's latest financial reports the company's total debt is โ‚น4.54 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Argenx - Total debt on balance sheet (from 2017 to 2020)

Total debt by year

Year Total debt Change
2025-12-31โ‚น4.23 B26.37%
2024-12-31โ‚น3.35 B101.22%
2023-12-31โ‚น1.66 B61.92%
2022-12-31โ‚น1.02 B20.5%
2021-12-31โ‚น0.85 B20.83%
2020-12-31โ‚น0.70 B35.32%
2019-12-31โ‚น0.52 B
2018-12-31N/A
2017-12-31N/A
2013-12-31N/A-100%
2012-12-31โ‚น0.16 B7.57%
2011-12-31โ‚น0.15 B